BOSTON — SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (LSE/STO/NYSE: AZN). PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with homologous recombination deficiency (HRD) in prostate cancer patients. The […]

The Endeavor® adds the fastest high-content cellular data generation to Ginkgo’s around-the-clock research  PORTLAND, Ore. and BOSTON — Araceli Biosciences and Ginkgo Bioworks (NYSE: DNA) today announced the integration of Araceli’s Endeavor® high-content imaging instrument into Nebula, Ginkgo’s autonomous lab in Boston. The Endeavor, the world’s fastest high-content imaging system, brings cellular imaging with real-time analysis […]

In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing models Illumina’s genomic AI models now collectively enable researchers to identify 2x as many variants with predicted biological impact SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of […]

Agreement enables BPS Bioscience to integrate Monod’s LuxSitTM Pro luciferase and NovoBodyTM binders into future discovery products and services SEATTLE and SAN DIEGO — Monod Bio and BPS Bioscience today announced a non-exclusive licensing agreement covering Monod Bio’s LuxSit Pro de novo luciferase and NovoBody binding proteins. BPS plans to integrate the technologies into the development […]

New facility expands Hudson’s space for product development and introduces a new customer demo lab CEO Werner Maas and other team members cut the ribbon during the grand opening ceremony Hudson Lab Automation, a global laboratory automation solutions provider, today announced the opening of its new headquarters in New Providence, New Jersey. The expanded facility […]

Multi-project collaboration with Fred Hutch Cancer Center spans biomarker discovery in bladder cancer and a single cell approach to residual disease detection in acute myeloid leukemia PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a multi-project research collaboration with Fred Hutchinson […]

NMPA approvals for Quanterix SIMOA® instruments and key neurology biomarker assays advance access to ultra-sensitive blood-based testing in China BILLERICA, Mass. & BEIJING — Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., Ltd. (SSE: 688253.SH), a leading in vitro diagnostics company in China, today announced regulatory approvals […]

Bringing together scientific and technical expertise to advance development of hardware and software aimed at enabling a new wave of AI-driven, autonomous biologics discovery Salt Lake City, Utah: Carterra®, a leading provider of high-throughput surface plasmon resonance (HT-SPR™) platforms for antibody and small molecule drug discovery, today announced a research collaboration with AstraZeneca to develop […]

Helping researchers to move from discovery to breakthrough up to 8x faster by combining AI, automation and innovation from across Danaher’s ecosystem of industry-leading technologies WASHINGTON — Danaher Corporation (NYSE: DHR) today announced plans to launch its first AI-powered autonomous lab, designed to help researchers develop custom antibodies and other molecular tools faster and more efficiently. […]

Amsbio has expanded its range of high-quality FFPE tissues and controls specifically designed to support biomarker discovery, histopathology, translational research and assay development. Although the tissue structure in FFPE samples is maintained for histological analysis, damage to the RNA incurred through the fixation, embedding, and storage processes advances with time and storage temperature. Sub-optimal tissue […]